• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Regeneron joins Koneksa Parkinson's digital biomarker study

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 04, 2024 at 11:42: AM
via Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patients with Parkinson's disease.

article source
 




Top Bottom
Back
Quote